Elevance Health (ELV)

• Market cap: $70.2B
• 1 day: -0.99%
• 5 days: -1.22%
• 1 month: 6.59%
• 3 months: -19.28%
• 6 months: -24.15%
• Year to date: -14.78%
• 1 year: -42.89%
• 5 years: 17.38%
• 10 years: 113.72%
• Sector: Healthcare
• Industry: Healthcare Plans

About: Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Employees: 104,200

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

43% more call options, than puts

Call options by funds: $706M | Put options by funds: $495M

2.19% more ownership

Funds ownership: 88.12% [Q1] → 90.32% (+2.19%) [Q2]

2% less repeat investments, than reductions

Existing positions increased: 590 | Existing positions reduced: 599

5% less funds holding

Funds holding: 1,636 [Q1] → 1,562 (-74) [Q2]

9% less capital invested

Capital invested by funds: $87.1B [Q1] → $79.2B (-$7.81B) [Q2]

22% less first-time investments, than exits

New positions opened: 142 | Existing positions closed: 181

26% less funds holding in top 10

Funds holding in top 10: 43 [Q1] → 32 (-11) [Q2]

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $297
• Avg. target: $359
• High target: $440

9 analyst ratings

• positive: 7 78%
• neutral: 2 22%
• negative: 0 0%

UBS A.J. Rice	$425	Buy Maintained	5 Sep 2025
Barclays Andrew Mok	$373	Overweight Maintained	4 Sep 2025
Wells Fargo Stephen Baxter	$330	Overweight Maintained	15 Aug 2025
Baird Michael Ha	$297	Neutral Maintained	25 Jul 2025
JP Morgan Lisa Gill	$384	Overweight Maintained	22 Jul 2025